Free Trial
ETR:AFX

Carl Zeiss Meditec (AFX) Stock Price, News & Analysis

Carl Zeiss Meditec logo
€59.70 +1.40 (+2.40%)
As of 05/27/2025

About Carl Zeiss Meditec Stock (ETR:AFX)

Key Stats

Today's Range
€57.65
€60.10
50-Day Range
€48.74
€69.00
52-Week Range
€54.60
€123.75
Volume
149,308 shs
Average Volume
94,405 shs
Market Capitalization
$5.56 billion
P/E Ratio
31.90
Dividend Yield
1.84%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Receive AFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

AFX Stock News Headlines

July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.
J.P. Morgan Sticks to Their Sell Rating for Carl Zeiss Meditec (0DHC)
See More Headlines

AFX Stock Analysis - Frequently Asked Questions

Carl Zeiss Meditec's stock was trading at €45.52 on January 1st, 2025. Since then, AFX shares have increased by 31.2% and is now trading at €59.70.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Carl Zeiss Meditec investors own include Intel (INTC), Meta Platforms (META), NVIDIA (NVDA), Volkswagen (VOW3), AbbVie (ABBV), Chevron (CVX) and Siemens Aktiengesellschaft (SIE).

Industry, Sector and Symbol

Stock Exchange
ETR
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
ETR:AFX
CIK
N/A
Fax
N/A
Employees
4,950
Year Founded
N/A

Profitability

Trailing P/E Ratio
31.90
Forward P/E Ratio
20.44
P/E Growth
2.83
Net Income
$185.59 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.64 billion
Cash Flow
€0.04 per share
Price / Cash Flow
1,398.28
Book Value
€22.92 per share
Price / Book
2.61

Miscellaneous

Free Float
N/A
Market Cap
$5.56 billion
Optionable
Not Optionable
Beta
0.98
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (ETR:AFX) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners